Hi Matt
Always enjoy your commentary.
I'm curious as to why you think further capital expenditure will be necessary for Peak when the last two Ann's have stated that no further spending would be required. Is there info about this in these Ann's that I've missed?
I agree cash burn has been high, but if no further funding required for Peak, this should reduce significantly in the coming quarters. The 4c suggests 5 quarters worth of funding at this rate, and doesn't take into account any patient growth. AGH has also suggested cost of goods should reduce following Peak becoming operational. What level do you think the next CR would be at, if required?
100% agree that UK and Germany aren't worth it at this point. Holding out hope that customer numbers pick up rapidly there as the cost is too high.
Hi Matt Always enjoy your commentary.I'm curious as to why you...
-
- There are more pages in this discussion • 150 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AGH (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
1.9¢ |
Change
0.001(5.56%) |
Mkt cap ! $7.701M | |||
| Open | High | Low | Value | Volume |
| 1.8¢ | 1.9¢ | 1.8¢ | $21.02K | 1.153M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 2454338 | 1.8¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 1.9¢ | 587081 | 4 |
View Market Depth
| Last trade - 16.10pm 26/07/2024 (20 minute delay) ? |
| AGH (ASX) Chart |